Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: Shadow who wrote (3201)	10/14/1999 10:31:00 PM
From: RSH	Read Replies (2) \| Respond to of 3369

Could you be more specific as to the source of this rumor As you're probably aware Shadow, sources of rumors are usually not discernible. The popular quote "buy on rumors, and sell on news" usually tends to be accurate. This stock has a history of very slimey offshore (Cayman Islands) deals Shadow, is this a statement of fact that you can back up with proof and a "source" for this "offshore" information, or is this merely a rumor that you heard yet you aren't able to prove? Slimey offshore deals have nothing to do with the outstanding rapid HIV test that (SALV) manufactures. Do you believe that Saliva Diagnostic's product is non-existent? Do you believe that they have no foreign contracts in existence? Do you believe that with an FDA approval of (SALV)'s rapid HIV diagnostic test, this product would not sell several hundred millions of $ annually? A company with rumors of shady deals has nothing to do with Meridian Diagnostics (KITS) interest in owning the best, fastest, and most accurate rapid HIV product available in the world. Meridian Diagnostics (KITS) needs (SALV)'s rapid HIV test kit in order to diversify its inventory and continue in its vertically integrated acquisition plans. In conclusion, Saliva Diagnostics (SALV) only has 8.11 million outstanding shares and a Market Cap of only $~2.5 million. Look at this product again and tell me that when it receives the FDA approval it will not be a breakthrough for the medical diagnostic and HIV detection industry. salv.com Everyone should always proceed with caution when purchasing stocks, however, the product speaks for itself and will change the medical industry. In fact, once the product receives the FDA approval, it would be available for home use. It would be inexpensive ($5-10) and results could be seen in five (5) minutes. Such a rapid HIV test will give humanity peace of mind in knowing that they can receive HIV information confidentially in the comfort of their own home. Best of luck to all of you investors that believe in this product's potential. Sincerely, Ron